Connected Care Updates – February 27

This update includes: Alliance for Connected Care letter for MAC Meeting DEA NPRM for Telemedicine Prescribing of Controlled Substances HRSA Request to Extend Telehealth Outcome Measures Introduced Telehealth Legislation and notable research and news developments

2023-02-27T18:51:42-04:00February 27th, 2023|

Drug Enforcement Administration Notice of Proposed Rulemaking Summary

Telemedicine prescribing of controlled substances when the practitioner and the patient have not had a prior in-person medical evaluation (RIN: 1117-AB40)Drug Enforcement Administration Notice of Proposed RulemakingPublic comments due March 31, 2023DEA Resources: Rule Text Highlights for Medical PractitionersDEA Summary ChartSee companion buprenorphine rule summary hereProposed Rule OverviewThe Ryan Haight Act of 2008 directed the [...]

2023-03-16T17:43:46-04:00February 27th, 2023|

Summary of Expansion of Induction of Buprenorphine via Telemedicine Encounter

The Drug Enforcement Administration (DEA) released its Notice of Proposed Rulemaking (NPRM) on buprenorphine via telemedicine encounter, a summary, and highlights for medical practitioners. The proposed rule amends the DEA’s regulations, in concert with the Department of Health and Human Services (HHS), on the circumstances under which individual practitioners are authorized to prescribe schedule [...]

2023-03-07T14:11:03-04:00February 27th, 2023|

Connected Care Updates – February 6

This update includes: Call for RPM data Introduction of the Telehealth Benefit Expansion for Workers Act Telehealth Website Update on Questions Remain Around Medicare Administrative Contractors (MAC) Meeting as Groups Prepare and notable research and news developments

2023-02-07T12:03:56-04:00February 6th, 2023|
Go to Top